XU Guowang of CAS Dalian Instiute of Chemical Physics’ Institute of Biotechnology has found a new biomarker pattern consisting of phenylalanyl-tryptophan and glycocholate with a higher diagnostic performance than α-fetoprotein (AFP), which is the traditional biomarker for HCC. 80.6% of the AFP false-negative patients with HCC were correctly diagnosed using this panel in a test set of 1448 individuals in 6 hospitals.
CAS news release, October 27, 2017
CAS DICP team finds novel biomarkers for early diagnosis of hepatocellular carcinoma (HCC)